Q

Qiming Venture Partners USA

15 employees

Qiming Venture Partners is a venture capital firm that offers early-stage healthcare possibilities in highly disruptive platforms.

Investor insights

Sectors invested in

Biotechnology17
Health Care15
Pharmaceutical10
Therapeutics6
Medical6
Biopharma6
Information Technology3
healthcare3
technology3
Vaccine2
VLPs2
Vaccines2
Respiratory syncytial virus2
Infectious Disease2
RSV2
Vaccine Development2
socialdeterminantsofhealth2
healthinequities2
venturecapital2
healthtech2

Funding rounds participated in

$59M sweet spot round size

Most of their 24 investments are in rounds between $36M and $100M

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Business Development
Venture Capital

Date founded

2017

Investments made

E

Entact Bio raised $81M on December 6, 2022

Investors: Logos Global Management, LP, Surveyor Capital, venBio Partners, Brandon Capital Partners, Abingworth and Qiming Venture Partners USA

S

Soda Health raised $25M on September 13, 2022

Investors: Lightspeed Venture Partners, Define Ventures and Qiming Venture Partners USA

A

Auron Therapeutics raised $48M on July 20, 2022

Investors: Apollo Ventures, Casdin Capital, LLC, DCVC Bio, Polaris Partners and Qiming Venture Partners USA

B

Boulder Care raised $36M on June 10, 2022

Investors: Alumni Ventures Group, Goodwater Capital, Tusk Ventures, Laerdal Million Lives Fund, Greycroft and Qiming Venture Partners USA

K

Korro Bio, Inc. raised $116M on January 5, 2022

Investors: MP Healthcare Venture Management Inc, The Invus Group, Surveyor Capital, Sixty Degree Capital, Monashee Investment Management LLC, Point72 Asset Management, Wu Capital （双湖资本） and Qiming Venture Partners USA

J

Jasper Therapeutics raised $100M on September 27, 2021

Investors: Avego Healthcare Capital, Velan Capital, Kingdon Capital Management, Metalmark Capital, Woodline Partners LP, Apeiron Investment Group and Qiming Venture Partners USA

V

Ventyx Biosciences raised $51M on September 20, 2021

Investors: Third Point LLC, Surveyor Capital, Vivo Capital, venBio Partners, RTW Investments, LP, OrbiMed Advisors, Logos Global Management, LP, Wellington Management and Qiming Venture Partners USA

H

HilleVax raised $135M on September 8, 2021

Investors: Greenspring Associates, Sahsen Ventures, LLC, Frazier Healthcare Partners, Richard King Mellon Foundation, Samsara BioCapital, Perceptive Advisors, Lightspeed Venture Partners, RA Capital Management, L.P. and Qiming Venture Partners USA

S

Soda Health raised $6M on August 19, 2021

Investors: Lightspeed Venture Partners and Qiming Venture Partners USA

U

Undisclosed raised $150M on June 8, 2021

Investors: Casdin Capital, LLC, Optum Ventures, Leerink Transformation Partners, Illumina Ventures, HLM Venture Partners and Qiming Venture Partners USA

FAQ